Table 1 Demographic characteristics and pre-, intra-, and postoperative data of study participants
IHD (N = 28) | Non-IHD (N = 33) | p-value | |
|---|---|---|---|
Male, n (%) | 18 (60.7) | 16 (50.3) | 0.744 |
Age, years (SD) | 74.5 (7.0) | 72.9 ± 9.4 | 0.339 |
HTN, n (%) | 25 (89.2) | 31 (93.9) | 0.653 |
DM, n (%) | 10 (35.7) | 14 (42.4) | 0.611 |
CVD, n (%) | 5 (17.9) | 8 (24.2) | 0.540 |
Peripheral arterial disease, n (%) | 1 (3.6) | 3 (9.1) | 0.618 |
Serum creatinine, mg/dL (SD) | 2.7 (1.1) | 2.3 (1.1) | 0.131 |
eGFR, mL/min/1.73 m2 (SD) | 19.5 (5.9) | 22.2 (5.2) | 0.056 |
CKD G4, n (%) | 19 (67.9) | 28 (84.9) | 0.138 |
CKD G5, n (%) | 9 (32.1) | 5 (15.2) | |
BUN, mg/dL (SD) | 41.5 (18.6) | 40.4 (16.7) | 0.811 |
Serum albumin, g/dL (SD) | 3.3 (0.7) | 3.3 (0.6) | 0.988 |
Serum potassium, mEq/L (SD) | 4.5 (0.4) | 4.4 (0.6) | 0.435 |
Preoperative medication, n (%) | |||
β-blocker | 15 (53.6) | 7 (21.2) | 0.073 |
Statin | 18 (64.3) | 21 (63.6) | 0.980 |
RAS-inhibitor | 15 (53.6) | 13 (39.4) | 0.501 |
Preoperative Hb, g/dL (SD) | 10.8 (1.6) | 11.0 (1.5) | 0.587 |
Postoperative Hb, g/dL (SD) | 10.8 (1.2) | 10.0 (1.0) | 0.005 |
Preoperative EF, % (SD) | 55.2 (12.8) | 56.5 (14.0) | 0.708 |
Blood transfusion during operation, mL (SD) | 1330 (709) | 1324 (860) | 0.975 |
Type of surgery | |||
CABG, n | 8 | 16 | 0.291 |
CABG + valve operation, n | 4 | 2 | |
AVR, n | 5 | 7 | |
MVR, n | 1 | 4 | |
MVP, n | 5 | 1 | |
TAA repair, n | 2 | 1 | |
Other procedures, n | 3 | 2 | |
IABP, n (%) | 1 (3.6) | 4 (12.1) | 0.262 |
Perioperative medications | |||
Inotropic agents, n (%) | 12 (42.9) | 14 (42.4) | 0.983 |
Diuretics, n (%) | 25 (89.3) | 22 (66.7) | 0.452 |
Glucocorticoids, n (%) | 3 (10.7) | 1 (3.0) | 0.259 |
Carperitide, n (%) | 5 (17.9) | 9 (27.3) | 0.489 |